-
The latest data of "fenerone" announced! What is the efficacy and safety in obese patients
Time of Update: 2023-01-07
Previous studies: Phenirenal ketone confers cardiac and renal benefits in type 2 diabetes Finerenone is a selective nonsteroidal mineralocorticoid receptor antagonist (MRA), and the FIDELITY study (pooled analysis of the FIDELIO-DKD and FIGARO-DKD studies) showed that fenelidone reduced the risk of cardiovascular (CV) and renal outcomes in patients with type 2 diabetes and chronic kidney disease (CKD).
-
Express shows nearly 95% protection! GSK's marketing application for RSV vaccine is imminent
Time of Update: 2022-10-20
▎WuXi AppTec content team editorGSK today announced positive results in a pivotal Phase 3 clinical trial of its bivalent respiratory syncytial virus (RSV) vaccine candidate.
▎WuXi AppTec content team editorGSK today announced positive results in a pivotal Phase 3 clinical trial of its bivalent respiratory syncytial virus (RSV) vaccine candidate.
-
100 million-level best-selling cardiovascular drug Chengdu Bitedigoxin Tablets is the first to review
Time of Update: 2022-05-18
On April 19, NMPA's official website released the latest information on approved drugs, and Chengdu Beite Pharmaceutical's digoxin tablets were the first to be reviewed .
On April 19, NMPA's official website released the latest information on approved drugs, and Chengdu Beite Pharmaceutical's digoxin tablets were the first to be reviewed .
-
Nat Med: Long-Term Cardiovascular Outcomes in COVID-19 Patients
Time of Update: 2022-03-03
arrhythmia thrombosisThus, this study provides evidence that the risk and 1-year burden of cardiovascular disease in survivors of acute COVID-19 is substantial .
This study provides evidence that the risk and 1-year burden of cardiovascular disease in survivors of acute COVID-19 is substantial .
-
Alzheimer&Dementia: Control blood sugar, stabilize glycation, diabetes can double the risk of dementia
Time of Update: 2021-11-02
Diabetic cognitive impairment (usually the prodromal stage of dementia) affects 20% of people 65 years of age or older, and about one-third of these cases will develop dementia within 5 years .
-
How to save hair loss
Time of Update: 2021-09-28
In a recent article published in the journal Nature, a team of researchers at Tokyo Medical and Dental University (TMDU) used mouse model experiments to study how high-fat diets or gene-induced obesity affect hair thinning and loss .
-
Bayer has gained control of the BlueRock stem cell joint venture
Time of Update: 2021-02-25
The decision gives Bayer full control of the BlueRock cell therapy pipeline, led by Parkinson's disease candidates, and will begin clinical trials of the disease this year, covering a variety of diseases in the neurology, cardiology and immunology categories.
-
Who will be the first to apply for conformity assessment of 2 billion aspirin varieties
Time of Update: 2019-12-13
Aspirin enteric coated tablet is a commonly used drug for the elderly It is widely used in clinic and has created a considerable market share It plays an important role in antithrombotic treatment and
-
Did you make it? What do countries in the world think of Chinese medicine
Time of Update: 2014-11-05
In the past five years, the author searched the literature reports on traditional Chinese medicine on Science Daily, and found that almost all of them were disapproval or criticism of traditional Chin
-
BD of the United States enters the low-end market of generic drugs
Time of Update: 2013-05-13
Source: first financial daily May 13, 2013, the world's largest medical technology company, BD, which entered the Chinese market 20 years ago and barely spoke, suddenly announced a series of ambitious
